Bio Essence Corp
OTC:BIOE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.051
0.34
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
B
|
Bio Essence Corp
OTC:BIOE
|
1.9m USD |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
103.4B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
69B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
69.1B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.9B USD |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
33.5B GBP |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35.5B AUD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.6B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.2B CNY |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Bio Essence Corp
Glance View
Bio Essence Corp. engages in the provision of integrated health supplements and research-intensive products. The company is headquartered in Irvine, California. The company went IPO on 2022-03-30. The firm provides herbal health, diet, and vitamin nutritional supplements through three operational subsidiaries, namely Bio Essence Pharmaceutical, Inc. (BEP) that helps to serves as a health supplement original equipment manufacturer (OEM) service; Bio Essence Herbal Essentials Inc. (BEH), which provides products and service through practitioners' market, and McBE Pharma, Inc. (McBE), which focuses on developing, manufacturing, and sales prescription drugs. Bio Essence Herbal Essentials Inc. targets healthcare practitioners with herbal products in the form of granules, capsules, pills, and tablets. The firm also offers special formulation service to practitioners. Bio Essence provides customers direct connections with integrative healthcare practitioners, such as dietitians, nutraceutical practitioners, and other practitioners.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Bio Essence Corp is -28.4%, which is above its 3-year median of -199%.
Over the last 3 years, Bio Essence Corp’s Net Margin has increased from -68.7% to -28.4%. During this period, it reached a low of -476.3% on Mar 31, 2025 and a high of -28.4% on Oct 30, 2025.